Literature DB >> 29019209

[Function of SIRT6 in tumor initiation and progression].

Zhen Dong1, Qian Lei1, Lichao Liu2, Hongjuan Cui1.   

Abstract

As a member of the sirtuins family, also called Class III histone deacetylases (HDACs), SIRT6 has many catalytic enzyme activities and plays a pivotal role in biological processes including anti-aging, chromatin regulation, transcriptional control, glucose and lipid metabolism, and DNA damage repair. Recently, increasing evidences indicated that SIRT6 was related to initiation and development of tumors, such as hepatic cancer, lung cancer, breast cancer and genital system tumors. However, SIRT6 might play a dual role in tumorigenesis and progression. SIRT6 often acted as a tumor suppressor, but might play an oncogenic role. Based on our current study, we depicted the essential roles of SIRT6 in the initiation and progression of various tumors, and summarized its mode of actions, which might provide clues for cancer therapy.

Entities:  

Keywords:  SIRT6; Warburg effect; histone deacetylases (HDACs); tumor development; tumor initiation

Mesh:

Substances:

Year:  2016        PMID: 29019209     DOI: 10.13345/j.cjb.150403

Source DB:  PubMed          Journal:  Sheng Wu Gong Cheng Xue Bao        ISSN: 1000-3061


  2 in total

1.  Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells.

Authors:  Qiufen Zhang; Yingyi Chen; Duan Ni; Zhimin Huang; Jiacheng Wei; Li Feng; Jun-Cheng Su; Yingqing Wei; Shaobo Ning; Xiuyan Yang; Mingzhu Zhao; Yuran Qiu; Kun Song; Zhengtian Yu; Jianrong Xu; Xinyi Li; Houwen Lin; Shaoyong Lu; Jian Zhang
Journal:  Acta Pharm Sin B       Date:  2021-07-02       Impact factor: 11.413

Review 2.  Clinicopathological and prognostic value of SIRT6 in patients with solid tumors: a meta-analysis and TCGA data review.

Authors:  Xiaojing Wu; Shuyuan Wang; Xuanzhu Zhao; Sizhen Lai; Zhen Yuan; Yixiang Zhan; Kemin Ni; Zhaoce Liu; Lina Liu; Ran Xin; Xingyu Zhou; Xin Yin; Xinyu Liu; Xipeng Zhang; Wei Cui; Chunze Zhang
Journal:  Cancer Cell Int       Date:  2022-02-16       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.